263 related articles for article (PubMed ID: 34523148)
21. Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease.
Uddin MS; Kabir MT; Niaz K; Jeandet P; Clément C; Mathew B; Rauf A; Rengasamy KRR; Sobarzo-Sánchez E; Ashraf GM; Aleya L
Molecules; 2020 Mar; 25(6):. PubMed ID: 32168835
[TBL] [Abstract][Full Text] [Related]
22. Natural products against Alzheimer's disease: Pharmaco-therapeutics and biotechnological interventions.
Dey A; Bhattacharya R; Mukherjee A; Pandey DK
Biotechnol Adv; 2017; 35(2):178-216. PubMed ID: 28043897
[TBL] [Abstract][Full Text] [Related]
23. Neuroinflammation in pathogenesis of Alzheimer's disease: Phytochemicals as potential therapeutics.
Vaiserman A; Koliada A; Lushchak O
Mech Ageing Dev; 2020 Jul; 189():111259. PubMed ID: 32450086
[TBL] [Abstract][Full Text] [Related]
24. Berberine suppresses amyloid-beta-induced inflammatory response in microglia by inhibiting nuclear factor-kappaB and mitogen-activated protein kinase signalling pathways.
Jia L; Liu J; Song Z; Pan X; Chen L; Cui X; Wang M
J Pharm Pharmacol; 2012 Oct; 64(10):1510-21. PubMed ID: 22943182
[TBL] [Abstract][Full Text] [Related]
25. Berberine ameliorates lipopolysaccharide-induced learning and memory deficit in the rat: insights into underlying molecular mechanisms.
Sadraie S; Kiasalari Z; Razavian M; Azimi S; Sedighnejad L; Afshin-Majd S; Baluchnejadmojarad T; Roghani M
Metab Brain Dis; 2019 Feb; 34(1):245-255. PubMed ID: 30456649
[TBL] [Abstract][Full Text] [Related]
26. Neuroprotective effects of bergenin in Alzheimer's disease: Investigation through molecular docking, in vitro and in vivo studies.
Barai P; Raval N; Acharya S; Borisa A; Bhatt H; Acharya N
Behav Brain Res; 2019 Jan; 356():18-40. PubMed ID: 30118774
[TBL] [Abstract][Full Text] [Related]
27. Pre-Clinical Neuroprotective Evidences and Plausible Mechanisms of Sulforaphane in Alzheimer's Disease.
Kim J
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805772
[TBL] [Abstract][Full Text] [Related]
28. Benzenediol-berberine hybrids: multifunctional agents for Alzheimer's disease.
Jiang H; Wang X; Huang L; Luo Z; Su T; Ding K; Li X
Bioorg Med Chem; 2011 Dec; 19(23):7228-35. PubMed ID: 22041172
[TBL] [Abstract][Full Text] [Related]
29. Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review.
Shinjyo N; Parkinson J; Bell J; Katsuno T; Bligh A
J Integr Med; 2020 Mar; 18(2):125-151. PubMed ID: 32005442
[TBL] [Abstract][Full Text] [Related]
30. Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer's disease.
Landlinger C; Oberleitner L; Gruber P; Noiges B; Yatsyk K; Santic R; Mandler M; Staffler G
J Neuroinflammation; 2015 Aug; 12():150. PubMed ID: 26275910
[TBL] [Abstract][Full Text] [Related]
31. Berberine attenuates cognitive impairment and ameliorates tau hyperphosphorylation by limiting the self-perpetuating pathogenic cycle between NF-κB signaling, oxidative stress and neuroinflammation.
He W; Wang C; Chen Y; He Y; Cai Z
Pharmacol Rep; 2017 Dec; 69(6):1341-1348. PubMed ID: 29132092
[TBL] [Abstract][Full Text] [Related]
32. Recent advances in the neurobiology and neuropharmacology of Alzheimer's disease.
Kumar K; Kumar A; Keegan RM; Deshmukh R
Biomed Pharmacother; 2018 Feb; 98():297-307. PubMed ID: 29274586
[TBL] [Abstract][Full Text] [Related]
33. In vitro antiglycating effect and in vivo neuroprotective activity of Trigonelline in d-galactose induced cognitive impairment.
Chowdhury AA; Gawali NB; Bulani VD; Kothavade PS; Mestry SN; Deshpande PS; Juvekar AR
Pharmacol Rep; 2018 Apr; 70(2):372-377. PubMed ID: 29477946
[TBL] [Abstract][Full Text] [Related]
34. A comprehensive review on the prevention and regulation of Alzheimer's disease by tea and its active ingredients.
Huang Y; Wei Y; Xu J; Wei X
Crit Rev Food Sci Nutr; 2023; 63(30):10560-10584. PubMed ID: 35647742
[TBL] [Abstract][Full Text] [Related]
35. Tea polyphenols as multi-target therapeutics for Alzheimer's disease: An in silico study.
Mazumder MK; Choudhury S
Med Hypotheses; 2019 Apr; 125():94-99. PubMed ID: 30902161
[TBL] [Abstract][Full Text] [Related]
36. Berberine modulates amyloid-β peptide generation by activating AMP-activated protein kinase.
Zhang H; Zhao C; Cao G; Guo L; Zhang S; Liang Y; Qin C; Su P; Li H; Zhang W
Neuropharmacology; 2017 Oct; 125():408-417. PubMed ID: 28822725
[TBL] [Abstract][Full Text] [Related]
37. Recent therapeutic strategies targeting beta amyloid and tauopathies in Alzheimer's disease.
Madav Y; Wairkar S; Prabhakar B
Brain Res Bull; 2019 Mar; 146():171-184. PubMed ID: 30634016
[TBL] [Abstract][Full Text] [Related]
38. The Combined Therapy of Berberine Treatment with lncRNA BACE1-AS Depletion Attenuates Aβ
Ge Y; Song X; Liu J; Liu C; Xu C
Neurochem Res; 2020 Apr; 45(4):741-751. PubMed ID: 31898085
[TBL] [Abstract][Full Text] [Related]
39. Role of TREM2 in Alzheimer's Disease and its Consequences on β- Amyloid, Tau and Neurofibrillary Tangles.
Singh AK; Mishra G; Maurya A; Awasthi R; Kumari K; Thakur A; Rai A; Rai GK; Sharma B; Kulkarni GT; Singh SK
Curr Alzheimer Res; 2019; 16(13):1216-1229. PubMed ID: 31481003
[TBL] [Abstract][Full Text] [Related]
40. Liraglutide Protects Against Brain Amyloid-β
Duarte AI; Candeias E; Alves IN; Mena D; Silva DF; Machado NJ; Campos EJ; Santos MS; Oliveira CR; Moreira PI
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32143329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
